Predicted Trait | |
Reported Trait | Severe COVID-19 course |
Mapped Trait(s) | COVID-19 (MONDO_0100096) |
Score Construction | |
PGS Name | pgs_data_ldpred |
Development Method | |
Name | Ldpred2 |
Parameters | r2=0.021, p=0.01000, h2=0.8035 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 955,503 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000666 |
Citation (link to publication) | Kovalenko E et al. Front Med (Lausanne) (2024) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
Europe PMC: 10.1038/s41586-023-06355-3 |
[
|
African unspecified | NR |
Europe PMC: 10.1038/s41586-023-06355-3 |
[
|
Hispanic or Latin American | NR |
Europe PMC: 10.1038/s41586-023-06355-3 |
[
|
East Asian | NR |
Europe PMC: 10.1038/s41586-023-06355-3 |
[
|
European | NR |
Europe PMC: 10.1038/s41586-023-06355-3 |
[
|
Greater Middle Eastern (Middle Eastern, North African or Persian) | NR |
Europe PMC: 10.1038/s41586-023-06355-3 |
[
|
Not reported | NR |
Europe PMC: 10.1038/s41586-023-06355-3 |
[
|
South Asian | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM021730 | PSS011763| European Ancestry| 7,124 individuals |
PGP000666 | Kovalenko E et al. Front Med (Lausanne) (2024) |
Reported Trait: Severe COVID-19 course | — | AUROC: 0.6 | Odds ratio (OR, high vs low tertile): 2.25 | PC1-20, sex, gender | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011763 | Very severe respiratory confirmed covid vs. not severe respiratory confirmed covid | — | [
|
— | European | — | Genotek | — |